stannous fluoride toothpaste

Phase 3

CColgate Palmolive

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[2][1]

Indication

PlaqueNot yet recruiting

PlaquePhase 3

Not yet recruiting

Timeline

Expected Milestones

Q2 2027

ApprovedNot yet recruiting

Gingival Inflammation

NCT06966492

Q3 2027

ApprovedNot yet recruiting

Periodontal Disease

NCT07807397

Clinical

Trials by Indication[1]

Periodontal Disease1 trial

Oral Hygiene Assistance Training Program

Not yet recruiting·CColgate Palmolive·Approved·NCT07807397·500 enrolled

Gingival Inflammation1 trial

Investigation of the Interplay Between Local Oral Inflammation, Microbiota and Systemic Immune Responses.

Not yet recruiting·CColgate Palmolive·Approved·NCT06966492·20 enrolled

Plaque1 trial

A Clinical Study to Investigate Stannous Fluoride Containing Toothpaste on Antibacterial Effects in the Different Regions of the Mouth as Compared to Colgate Cavity Protection Toothpaste.

Not yet recruiting·CColgate Palmolive·Phase 3·NCT07458464·100 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for stannous fluoride toothpaste. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for stannous fluoride toothpaste. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Colgate Palmolive company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Phase 3[1]
Company: CColgate Palmolive